← Replacement Therapy
Replacement Therapy cover
Replacement Therapy · Episode 6 of 8 · 18 min

The Supply Line

Taking the readiness argument seriously and following it forward, a man on testosterone replacement depends on a delivery schedule rather than his own factory. The episode reasons from pharmacology about axis suppression, missed doses, fertility and the veterans' tail, and notes the department's own argument about pharmaceutical dependence. None of it has happened; it is what the pharmacology implies.

Who's who

Timeline

  1. July 15, 2026Screening program announced: mandatory at thirty and over, voluntary below
  2. July 16, 2026Endocrine Society objects within a day
  3. July 17, 2026Five senators write asking for evidence and a cost analysis
  4. July 22, 2026Judge Reyes directs the Pentagon to reconcile the program with the transgender exclusion
  5. September 2, 2026Defense Health Agency issues clinical guidance
  6. September 3, 2026Guidance withdrawn; interim screening guidance remains in effect

Still debated

The magnitude and timing of decline after a missed dose in young, previously healthy men have not been studied, and no prevalence data or cost estimate for the program is public. Whether the transgender exclusion rested solely on hormone-therapy grounds is also not established.

testosteronemilitary readinessaxis suppressionfertilitysupply chainpolicy contradiction
← PreviousThe High-T Department of War

Connected episodes in other series